A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Sponsored by Mirati Therapeutics Inc.
About this study
This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemotherapy in participants with previously untreated, locally advanced or metastatic NSCLC with KRAS G12C mutation
Where this study is enrolling (29)
- Call 562-693-4477
Helios Clinical Research
Long Beach, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 714-446-5900
Providence Medical Foundation
Fullerton, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 303-388-4461
National Jewish Health Medical Center
Denver, Colorado
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 302-366-1200
Medical Oncology Hematology Consultants, PA
Newark, Delaware
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 111-111-1111
Cancer Care Centers of Brevard, Inc.
Palm Bay, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Show all 29 locations
- Call 352-732-4938
Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala
Ocala, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 561-447-0614
Florida Clinical Trials Group.
Tamarac, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 561-447-0614
Florida Clinical Trials Group.
Plantation, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 407-353-1915
Mid Florida Hematology and Oncology Center
Orange City, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 813-745-6895
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 904-538-4488
Cancer Specialists of North Florida
Jacksonville, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital
Marietta, Georgia
- Call 847-827-9060
Illinois Cancer Specialists
Arlington Heights, Illinois
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 205-919-3812
Springfield Clinic Main Campus
Springfield, Illinois
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 260-266-7100
Parkview Research Center at Parkview Regional Medical Center
Fort Wayne, Indiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 219-924-8178
Northwest Cancer Centers, P.C.
Dyer, Indiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 502-562-4358
The University of Louisville, James Graham Brown Cancer Center
Louisville, Kentucky
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 859-301-4000
Saint Elizabeth Medical Center Edgewood
Edgewood, Kentucky
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 000-000-0000
Mercy Health-Paducah Medical Oncology and Hematology
Paducah, Kentucky
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 318-813-3061
Louisiana State University Health Sciences Shreveport
Shreveport, Louisiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 817-837-8660
Maryland Oncology Hematology - Columbia
Columbia, Maryland
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 914-849-7600
White Plains Hospital
White Plains, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 517-331-4405
Ellis Hospital
Schenectady, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 717-339-2560
WellSpan Oncology Research
York, Pennsylvania
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 864-603-6327
St Francis Cancer Center
Greenville, South Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 615-320-5090
SCRI Oncology Partners
Nashville, Tennessee
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 210-656-7177
Texas Oncology - San Antonio
San Antonio, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 903-727-2200
Texas Oncology - Northeast Texas
Tyler, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 214-370-1000
Texas Oncology Sammons Cancer Center
Dallas, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓Histologically or cytologically confirmed diagnosis of non-squamous NSCLC with evidence of KRAS G12C mutation via tumor sample and/or circulating tumor deoxyribonucleic acid (ctDNA).
- ✓Locally advanced or metastatic disease.
- ✓Measurable disease via computed tomography (CT) or magnetic resonance imaging (MRI) per RECIST v1.1 criteria of at least 1 lesion.
- ✓No prior systemic anti-cancer therapy given for advanced or metastatic disease.
- ✓Not a candidate for definitive therapy (eg, chemoradiation or complete surgical resection).
- ✓Participants with brain metastases are eligible for enrollment, including those with untreated brain metastases. Brain metastases must be asymptomatic and not in need of immediate local therapy. Any untreated brain metastases must be ≤ 20 mm in diameter.
- ✓Any PD-L1 expression (0 to 100%) as determined by VENTANA PD-L1 (SP263) assay, Agilent PD-L1 IHC 22C3 pharmDx, or Agilent PD-L1 IHC 28-8 pharmDx.
Exclusion criteria
- ✕Participants with an active autoimmune or inflammatory disease requiring systemic treatment within 2 years.
- ✕Uncontrolled or significant cardiovascular conditions within 6 months prior to enrollment that are ongoing or with risk of recurrence.
- ✕Inadequate bone marrow or liver function or electrocardiogram (ECG) abnormalities.
- ✕Ongoing treatment with concomitant medication known to cause prolonged QTc interval and that cannot be switched to alternative treatment prior to study entry.
- ✕Treatment targeting KRAS G12C mutation (eg, sotorasib, adagrasib) in any setting.
- ✕Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or study drug administration.
- ✕Other protocol-defined Inclusion/Exclusion criteria apply.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.